Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Brain Inflammation Collaborative
Cairo University
Bristol-Myers Squibb
M.D. Anderson Cancer Center
Leiden University Medical Center
HJN Sverige AB/Neko Health